Prozkoumejte nejčtenější články a videa na Campus Sanofi
This video presents results from the Phase 4 VESTIGE trial, demonstrating how dupilumab improves airway structure and function in severe type 2 asthma. Using breakthrough Functional Respiratory Imaging technology, the study reveals structural improvements that conventional lung function tests may not detect.
RSV is the primary cause of LRTIs in children worldwide.2 Infants aged 3 months old have the highest risk of severe RSV LRTIs.2
In Singapore, RSV circulates all-year round and causes significant paediatric health and economic burden.2 This highlights the need and importance of RSV immunisation to reduce the burden of disease.2
T1D is a chronic, autoimmune disease with a complex, multifactorial etiology. Explore how genetics and environmental factors can trigger autoimmunity